COVID-19: Most Taiwanese opposed to Chinese shots
Staff writer, with CNA
The majority of Taiwanese, or 76.1 percent, are unwilling to receive COVID-19 vaccines developed by Chinese firms, while 61.6 percent said the government should not import Chinese vaccines, a survey released yesterday by the Association of Chinese Elite Leadership showed as the nation reported one new imported case of COVID-19.
According to the survey, 19 percent of respondents were willing to receive a Chinese vaccine and 24.9 percent were open to the idea of importing Chinese vaccines.
Of the respondents, 28.5 percent identified themselves as Democratic Progressive Party (DPP) supporters and 18.6 percent as Chinese Nationalist Party (KMT) supporters.
PROGRESS: With the help of Taiwan’s Shinkong Wu Ho-su Memorial Hospital, Palau will hopefully have more than 50 percent of its population vaccinated by April 30By Lee I-chia / Staff reporter
The Central Epidemic Command Center (CECC) yesterday confirmed that it is mulling a “travel bubble” between Taiwan and Palau.
Centers for Disease Control (CDC) Deputy Director-General Chuang Jen-hsiang (莊人祥), who is the CECC’s spokesperson, said the travel bubble plan has been discussed continuously, and a meeting to conclude the matter would take place in the next few days.
Shinkong Wu Ho-su Memorial Hospital has been supporting medical treatment and COVID-19 testing in Palau, so it understands the situation there well, and there has not been any COVID-19 outbreak in Palau, he said.
A number of plans are being discussed, but the details would
RISK REDEFINED: Thirty million doses would be needed to vaccinate people in 10 priority groups, and paid vaccinations might be allowed later, the center saidBy Lee I-chia / Staff reporter
FDA authorizes AstraZeneca jab for use: CECC
COMING SOON: After the vaccines arrive, authorities would ensure they meet quality standards and they could be made available in a week or up to 40 days
By Lee I-chia / Staff reporter
The Central Epidemic Command Center (CECC) yesterday confirmed that the Food and Drug Administration (FDA) has issued emergency use authorization for the AstraZeneca COVID-19 vaccine from three factories, adding that it could be administered in about seven days after arrival in Taiwan.
FDA Director-General Wu Shou-mei (吳秀梅) said the agency approved the vaccine yesterday morning.
The vaccines could be administered as soon as seven days after they arrive in Taiwan, if all the required information is provided, but it could take up to 40 days if the factories provide incomplete documentation, she said.